.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
McKinsey
Chubb
Argus Health
Dow
Healthtrust
Daiichi Sankyo
McKesson
Farmers Insurance
Cipla

Generated: December 16, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 012911

« Back to Dashboard

NDA 012911 describes METOPIRONE, which is a drug marketed by Hra Pharma and is included in one NDA. It is available from one supplier. Additional details are available on the METOPIRONE profile page.

The generic ingredient in METOPIRONE is metyrapone. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the metyrapone profile page.

Summary for 012911

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 012911

Medical Subject Heading (MeSH) Categories for 012911

Suppliers and Packaging for NDA: 012911

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
METOPIRONE metyrapone CAPSULE;ORAL 012911 NDA Laboratoire HRA Pharma 76336-455 76336-455-18 18 CAPSULE, GELATIN COATED in 1 BOTTLE (76336-455-18)
METOPIRONE metyrapone TABLET;ORAL 012911 NDA Laboratoire HRA Pharma 76336-455 76336-455-18 18 CAPSULE, GELATIN COATED in 1 BOTTLE (76336-455-18)

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength250MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength250MG
Approval Date:Aug 9, 1996TE:RLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
McKesson
Farmers Insurance
Teva
Deloitte
Queensland Health
Colorcon
Healthtrust
Merck
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot